Skip to main content
SpringerLink
Log in

Autoimmune Endocrinopathies in Female Reproductive Dysfunction

  • Chapter
Autoimmune Endocrinopathies

Part of the book series: Contemporary Endocrinology ((COE,volume 15))

  • 161 Accesses

Abstract

Reproductive medicine is a discipline that deals with a peculiar set of organ systems whose concerted action is essential to species perpetuation. This discipline thrives on the intellectual contributions of biomedical researchers with diverse backgrounds. Reproductive endocrinology and reproductive immunology are two closely related fields of reproductive medicine that study the role of the endocrine and the immune systems in reproduction. The close association between these two specialties is further underlined by the practical consideration that currently many clinical reproductive immunologists have a background in either internal medicine or obstetrics and gynecology.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. McKinlay SM, Brambilla DJ, Posner JG. The normal menopause transition. Maturitas 1992;14: 103–115.

    Article  PubMed  CAS  Google Scholar 

  2. de Moraes-Ruehsen M, Jones GS. Premature ovarian failure. Fertil Steril 1967;18:440–461.

    Google Scholar 

  3. Rebar RW, Connolly HV. Clinical features of young women with hypergonadotropic amenorrhea. Fertil Steril 1990;53:804–810.

    PubMed  CAS  Google Scholar 

  4. Coulam CB, Adamson SC, Annegers J F. Incidence of premature ovarian failure. Obstet GGynecol 1986; 67:604–606.

    CAS  Google Scholar 

  5. Nelson LM, Anasti JN, Flack MR. Premature ovarian failure. In: Adashy EY, Rock JA, Rosenwaks Z, eds. Reproductive Endocrinology, Surgery, and Technology, 1st ed., vol. 2. Lippincott-Raven, Philadelphia, PA, 1996, pp. 1393–1410.

    Google Scholar 

  6. La Barbera AR, Miller MM, Ober C, Rebar RW. Autoimmune etiology in premature ovarian failure. Am J Reprod Immunol Microbiol 1988;16:115–122.

    Google Scholar 

  7. Weetman AP. Autoimmunity to steroid-producing cells and familial polyendocrine autoimmunity. Baillieres Clin Endocrinol Metab 1995;9:157–174.

    Article  PubMed  CAS  Google Scholar 

  8. Ahonen P, Myllarniemi S, Sipila I, Perheentupa J. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med 1990; 322:1829–1836.

    Article  PubMed  CAS  Google Scholar 

  9. Neufeld M, Maclaren NK, Blizzard RM. Two types of autoimmune Addison’s disease associated with different polyglandular autoimmune (PGA) syndromes. Medicine (Baltimore) 1981;60:355–362.

    Article  CAS  Google Scholar 

  10. Papadopoulos KI, Hallengren B. Polyglandular autoimmune syndrome type II in patients with idiopathic Addison’s disease. Acta Endocrinol (Copenh) 1990;122:472–478.

    CAS  Google Scholar 

  11. Turkington RW, Lebovitz HE. Extra-adrenal endocrine deficiencies in Addison’s disease. Am J Med 1967;43:499–507.

    Article  PubMed  CAS  Google Scholar 

  12. Irvine WJ, Chan MM, Scarth L, Kolb FO, Hartog M, Bayliss RI, et al. Immunological aspects of premature ovarian failure associated with idiopathic Addison’s disease. Lancet 1968;2:883–887.

    Article  PubMed  CAS  Google Scholar 

  13. Blizzard RM, Chee D, Davis W. The incidence of adrenal and other antibodies in the sera of patients with idiopathic adrenal insufficiency (Addison’s disease). Clin Exp Immunol 1967;2:19–30.

    PubMed  CAS  Google Scholar 

  14. Sotsiou F, Bottazzo GF, Doniach D. Immunofluorescence studies on autoantibodies to steroid-producing cells, and to germline cells in endocrine disease and infertility. Clin Exp Immunol 1980;39:97–111.

    PubMed  CAS  Google Scholar 

  15. Winqvist O, Karlsson FA, Kampe O. 21-Hydroxylase, a major autoantigen in idiopathic Addison’s disease [see comments]. Lancet 1992;339:1559–1562.

    Article  PubMed  CAS  Google Scholar 

  16. Baumann-Antczak A, Wedlock N, Bednarek J, Kiso Y, Krishnan H, Fowler S, et al. Autoimmune Addison’s disease and 21-hydroxylase [letter; comment]. Lancet 1992;340, 429–430.

    Article  PubMed  CAS  Google Scholar 

  17. Krohn K, Uibo R, Aavik E, Peterson P, Savilahti K. Identification by molecular cloning of an autoantigen associated with Addison’s disease as steroid 17 alpha-hydroxylase [see comments]. Lancet 1992;339:770–773.

    Article  PubMed  CAS  Google Scholar 

  18. Winqvist O, Gustafsson J, Rorsman F, Karlsson FA, Kampe O. Two different cytochrome P450 enzymes are the adrenal antigens in autoimmune polyendocrine syndrome type I and Addison’s disease. J Clin Invest 1993:92:2377–2385.

    Article  PubMed  CAS  Google Scholar 

  19. Uibo R, Aavik E, Peterson P, Perheentupa J, Aranko S, Pelkonen R, et al. Autoantibodies to cytochrome P450 enzymes P45Oscc, P450c17, and P450c21 in autoimmune polyglandular disease types I andd Tl andd in iSolatedl AddddiSon’S ddiSeaSe J Clin EEnddocrinol Metab 1994:78;323–328.

    CAS  Google Scholar 

  20. I aanddd II aanndd inn issoolateed A Addissoonn ss ddisease. J Clinn Enndocrin-l Mmetaab 19 9 4: 8323 328–20. Arif S, Vallian S, Farzaneh F, Zanone MM, James SL, Pietropaolo M, et al. Identification of 3 betahydroxysteroid dehydrogenase as a novel target of steroid cell autoantibodies: association of autoantibodies with endocrine autoimmune disease. J Clin Endocrinol Metab 1996;81:4439–4445.

    Google Scholar 

  21. Mignot MH, Schoemaker J, Kleingeld M, Rao BR, Drexhage HA. Premature ovarian failure. I: The association with autoimmunity. Eur J Obstet Gynecol Reprod Biol 1989;30:59–66.

    Article  PubMed  CAS  Google Scholar 

  22. Betterle C, Rossi A, Dalla Pria S, Artifoni A, Pedini B, Gavasso S, et al. Premature ovarian failure: autoimmunitv and natural history. Clin Endocrinol (Oxford) 1993;39:35–43.

    Article  CAS  Google Scholar 

  23. Elder M, Maclaren N, Riley W. Gonadal autoantibodies in patients with hypogonadism and/or Addison’s disease. J Clin Endocrinol Metab 1981;52:1137–1142.

    Article  PubMed  CAS  Google Scholar 

  24. Betterle C, Zanette F, Zanchetta R, Pedini B, Trevisan A, Mantero F, et al. Complement-fixing adrenal autoantibodies as a marker for predicting onset of idiopathic Addison’s disease. Lancet 1983; I: 123R-1241

    Google Scholar 

  25. Betterle C, Scalici C, Presotto F, Pedini B, Moro L, Rigon F, et al. The natural history of adrenal function in autoimmune patients with adrenal autoantibodies. J Endocrinol 1988;117:467–475.

    Article  PubMed  CAS  Google Scholar 

  26. Kim TJ, Anasti JN, Flack MR, Kimzey LM, Defensor RA, Nelson LM. Routine endocrine screening for patients with karyotypically normal spontaneous premature ovarian failure. Obstet Gynecol 1997; 89:777–779.

    Article  PubMed  CAS  Google Scholar 

  27. Betterle C, Presotto F, Pedini B, Moro L, Slack RS, Zanette F, et al. Islet cell and insulin autoantibodies in organ-specific autoimmune patients. Their behaviour and predictive value for the development of type 1 (insulin-dependent) diabetes mellitus. A 10-year follow-up study. Diabetologia 1987;30:292–297.

    Article  PubMed  CAS  Google Scholar 

  28. Ahonen P, Miettinen A, Perheentupa J. Adrenal and steroidal cell antibodies in patients with autoimmune polyglandular disease type I and risk of adrenocortical and ovarian failure. J Clin Endocrinol MMetab 19887:64:4994.-500

    Google Scholar 

  29. Hoek A, Shoemaker J, Drexage HA. Premature ovarian failure and ovarian autoimmunity. Endocr Rev 1997;18:107–134.

    Article  PubMed  CAS  Google Scholar 

  30. Bannatyne P, Russell P, Shearman RP. Autoimmune oophoritis: a clinicopathologic assessment of 12 cases. Int J Gynecol Pathol 1990;9:191–207.

    Article  PubMed  CAS  Google Scholar 

  31. Sedmak DD, Hart WR, Tubbs RR. Autoimmune oophoritis: a histopathologic study of involved ovaries with immunologic characterization of the mononuclear cell infiltrate. Int J Gynecol Pathol 1987;6:73–81.

    Article  PubMed  CAS  Google Scholar 

  32. Gloor E, Hurlimann J. Autoimmune oophoritis. Am J Clin Pathol 1984;81:105–109.

    PubMed  CAS  Google Scholar 

  33. Hill JA, Welch WR, Faris HM, Anderson DJ. Induction of class II major histocompatibility complex antigen expression in human granulosa cells by interferon gamma: a potential mechanism contributing to autoimmune ovarian failure. Am J Obstet Gynecol 1990;162:534–540.

    Article  PubMed  CAS  Google Scholar 

  34. Tung KS, Smith S, Teuscher CCC, Anderson RE. Murine autoimmune oophoritis, epididymo-orchitis, and gastritis induced by day 3 thymectomy. Am J Pathol 1987;126:293–302.

    PubMed  CAS  Google Scholar 

  35. Miyake T, Taguchi O, Ikeda H, Sato Y, Takeuchi S, Nishizuka Y. Acute oocyte loss in experimental autoimmune oophoritis as a possible model of premature ovarian failure. Am J Obstet Gynecol 1988; 158:186–192.

    PubMed  CAS  Google Scholar 

  36. Taguchi O, Nishizuka Y, Sakakura T, Kojima A. Autoimmune oophoritis in thymectomized mice: detection of circulating antibodies against oocytes. Clin Exp Immunol 1980;40:540–553.

    PubMed  CAS  Google Scholar 

  37. Miller ME, Chatten J. Ovarian changes in ataxia teleangectasia. Acta Paediatr Scand 1967;56:559–561.

    Article  PubMed  CAS  Google Scholar 

  38. Healy DL, Bacher J, Hodgen GD. Thymic regulation of primate fetal ovarian-adrenal differentiation. Biol Reprod 1985;32:1127–1133.

    Article  PubMed  CAS  Google Scholar 

  39. Smith H, Sakamoto Y, Kasai K, Tung KSK. Effector and regulatory cells in autoimmune oophoritis elicited by neonatal thymectomy. J Immunol 1991;147:2928–2933.

    PubMed  CAS  Google Scholar 

  40. Sakaguchi S, Takahashi T, Nishizuka Y. Study on cellular events in postthymectomy autoimmune oophoritis in mice. 1. Requirement of Lyt-1 effector cells for oocytes damage after adoptive transfer. J Exp Med 1982;156:1565–1576.

    Article  PubMed  CAS  Google Scholar 

  41. Smith H, Lou YH, Lacy P, Tung KS. Tolerance mechanism in experimental ovarian and gastric autoimmune diseases. J Immunol 1992;149:2212–2218.

    PubMed  CAS  Google Scholar 

  42. Aaltonen J, Bjorses P, Sandkuijl L, Perheentupa J, Peltonen L. An autosomal locus causing autoimmune disease: autoimmune polyglandular disease type I assigned to chromosome 21. Nat Genet 1994;8:83–87.

    Article  PubMed  CAS  Google Scholar 

  43. Dewhurst CJ, de Koos EB, Ferreira HP. The resistant ovary syndrome. Br J Obstet Gynaecol 1975; 82:341–345.

    Article  PubMed  CAS  Google Scholar 

  44. Kamada M, Daitoh T, Mori K, Maeda N, Hirano K, Irahara M, et al. Etiological implication of autoantibodies to zona pellucida in human female infertility. Am J Reprod Immunol 1992;28:104–109.

    Article  PubMed  CAS  Google Scholar 

  45. Dean J. Biology of mammalian fertilization: the role of the zona pellucida. J Clin Invest 1992;89: 1055–1059.

    Article  PubMed  CAS  Google Scholar 

  46. Rhim SH, Millar SE, Robey F, Luo AM, Lou YH, Yule T, et al. Autoimmune disease of the ovary induced by ZP3 peptide from the mouse zona pellucida. J Clin Invest 1992;89:28–35.

    Article  PubMed  CAS  Google Scholar 

  47. Lou Y, Tung KS. T cell peptide of a self-protein elicits autoantibody to the protein antigen. Implications for specificity and pathogenetic role of antibody in autoimmunity. J Immunol 1993;151: 5790–5799.

    PubMed  CAS  Google Scholar 

  48. Tilly JL, Aihara T, Nishimori K, Jia XC, Billig H, Kowalski KI, et al. Expression of recombinant human follicle-stimulating hormone receptor: species-specific ligand binding, signal transduction, and identification of multiple ovarian messenger ribonucleic acid transcripts. Endocrinology 1992;131:799–806.

    Article  PubMed  CAS  Google Scholar 

  49. Jia XC, Oikawa M, Bo M, Tanaka T, Boime I, Hsueh AJ. Expression of human luteinizing hormone receptor: interaction with LH and chorion gonadotropin from human, but not equine, rat, and ovine species. Mol Endocrinol 1991;5:759–768.

    Article  PubMed  CAS  Google Scholar 

  50. Anasti JN, Flack MR, Froelich J, Nelson LM. The use of human recombinant gonadotropin receptors to search for immunoglobulin G-mediated premature ovarian failure. J Clin Endocrinol Metab 1995; 80:824–828.

    Article  PubMed  CAS  Google Scholar 

  51. Ho PC, Tang GWK, Lawton JW. Lymphocyte subsets and serum immunoglobulins in patients with premature ovarian failure before and after oestrogen replacement. Hum Reprod 1993;8:714–716.

    PubMed  CAS  Google Scholar 

  52. Anasti JN, Adams S, Kimzey LM, Defensor RA, Zachary AA, Nelson LM. Karyotypically normal spontaneous premature ovarian failure: evaluation of association with class II major hi stocompatibility complex. J Clin Endocrinol Metab 1994;78:722–723.

    Article  PubMed  CAS  Google Scholar 

  53. Taylor PV, Campbell JM, Scott JS. Presence of autoantibodies in women with unexplained infertility [see comments]. Am J Obstet Gynecol 1989;161:377–379.

    Article  PubMed  CAS  Google Scholar 

  54. Blumenfeld Z, Halachmi S, Peretz BA, Shmuel Z, Golan D, Makler A, et al. Premature ovarian failure-the prognostic application of autoimmunity on conception after ovulation induction. Fertil Steril 1993;59:750–755.

    PubMed  CAS  Google Scholar 

  55. Corenblum B, Rowe T, Taylor PJ. High-dose, short-term glucocorticoids for the treatment of infertility resulting from premature ovarian failure. Fertil Steril 1993;59:988–991.

    PubMed  CAS  Google Scholar 

  56. Albrecht ED, Pepe GJ. Placental steroid hormone biosynthesis in primate pregnancy. Endocr Rev 1990;11:124.

    Article  PubMed  CAS  Google Scholar 

  57. Medawar PB. Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates. Academic, New York, 1953, Society for Experimental Biology, vol. 7.

    Google Scholar 

  58. U.S. Department of Health and Human Services. Reproductive impairment among married couples. US vital and health statistics. Hyattsville,MD: National Center for Health Statistics series 23,11, 1992, pp. 5–31.

    Google Scholar 

  59. Harlop S, Shiono PH, Ramcharan S. A life table of spontaneous abortions and the effects of age, parity and other variables. In: Porter IH, Hook EB, eds. Human Embryonic and Fetal Death. Academic, New York, 1980, p. 145.

    Google Scholar 

  60. Regan L. Recurrent miscarriage. Br Med J 1991;302:543–544.

    Article  CAS  Google Scholar 

  61. Regan L. Recurrent early pregnancy failure. Curr Opinion Obstet Gynaecol 1992;4:220–228.

    CAS  Google Scholar 

  62. Hill JA. Sporadic and recurrent spontaneous abortion. Curr Prob Obstet Gynecol Fertil 1994;17: 1i4–1622

    Google Scholar 

  63. Hill JA. Immunologic factors in spontaneous abortion. In: Bronson RA, Alexander NJ, Anderson DJ, Branch DW, Kutteh WH, eds. Reproductive Immunology. Blackwell Science, Cambridge, MA, 1996, pp. 433–442.

    Google Scholar 

  64. Lockshin DW. Answers to the antiphospholipid antibody syndrome? N Engl J Med 1995;332: 1025–1027.

    Article  PubMed  CAS  Google Scholar 

  65. Peaceman AM, Silver RK, MacGregor SN, Socol ML. Interlaboratory variation in antiphospholipid antibody testing [see comments]. Am J Obstet Gynecol 1992;166,1780–1784; discussion 1784–1787.

    Google Scholar 

  66. Harris EN. Special report. The Second International Anti-cardiolipin Standardization Workshop/the Kingston Anti-Phospholipid Antibody Study (KAPS) group. Am J Clin Pathol 1990:94:476–484.

    PubMed  CAS  Google Scholar 

  67. Asherson RA, Khamashta MA, Ordi-Ros J, Derksen RH, Machin SJ, Barquinero J, et al. The “primary” antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) 1989;68: 366–374.

    CAS  Google Scholar 

  68. Harris EN, Gharavi AE, Boey ML, Patel BM, Mackworth-Young CG, Loizou S, et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983;2:1211–1214.

    Article  PubMed  CAS  Google Scholar 

  69. Fort JG, Cowchock FS, Abruzzo JL, Smith JB. Anticardiolipin antibodies in patients with rheumatic diseases. Arthritis Rheum 1987:30:752–760.

    Article  PubMed  CAS  Google Scholar 

  70. Exner T, Sahman N, Trudinger B. Separation of anticardiolipin antibodies from lupus anticoagulant on a phospholipid-coated polystyrene column. Biochem Biophys Res Commun 1988;155:1001–1007.

    Article  PubMed  CAS  Google Scholar 

  71. Chamtley LW, Pattison NS, McKay EJ. Separation of lupus anticoagulant from anticardiolipin antibodies by ion-exchange and gel filtration chromatography. Haemostasis 1991:21:25–29.

    Google Scholar 

  72. Clifford K, Rai R, Watson H, Regan L. An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases. Hum Reprod 1994;9:1328–1332.

    PubMed  CAS  Google Scholar 

  73. Silver RM, Porter TF, van Leeuween I, Jeng G, Scott JR, Branch DW. Anticardiolipin antibodies: clinical consequences of “low titers.” Obstet Gynecol 1996:87:494–500.

    Article  PubMed  CAS  Google Scholar 

  74. Klinman HJ, Feinman MA, Strauss JFI. Differentiation of human cytotrophoblasts into syncytiotrophoblasts in culture. Trophoblast Res 1987;2:407–421.

    Google Scholar 

  75. Lyden TW, Ng AK, Rote NS. Modulation of phosphatidylserine epitope expression by BeWo cells during forskolin treatment. Placenta 1993;14:177–186.

    Article  PubMed  CAS  Google Scholar 

  76. Kwak JY, Gilman-Sachs A, Beaman KD, Beer AE. Reproductive outcome in women with recurrent spontaneous abortions of alloimmune and autoimmune causes: preconception versus postconception treatment. Am J Obstet Gynecol 1992;166:1787–1795; discussion 1795–1788.

    Google Scholar 

  77. Lechner K, Pabinger-Fasching I. Lupus anticoagulants and thrombosis. A study of 25 cases and review of the literature. Haemostasis 1985;15:254–262.

    PubMed  CAS  Google Scholar 

  78. Brey RL, Hart RG, Sherman DG, Tegeler CH. Antiphospholipid antibodies and cerebral ischemia in young people. Neurology 1990;40:1190–1196.

    Article  PubMed  CAS  Google Scholar 

  79. Ferro D, Quintarelli C, Rasura M, Antonini G, Violi F. Lupus anticoagulant and the fibrinolytic system in young patients with stroke. Stroke 1993;24:368–370.

    Article  PubMed  CAS  Google Scholar 

  80. Branch DW, Silver RM, Blackwell JL, Reading JC, Scott JR. Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet Gynecol 1992; 80:614–620.

    PubMed  CAS  Google Scholar 

  81. Glueck HI, Kant KS, Weiss MA, Pollak VE, Miller MA, Coots M. Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulants. Arch Intern Med 1985;145: 1389–1395.

    Article  PubMed  CAS  Google Scholar 

  82. Petri M, Golbus M,erson R, Whiting OKQ, Corash L, Hellmann D. Antinuclear antibody, lupus anticoagulant, and anticardiolipin antibody in women with idiopathic habitual abortion. A controlled, prospective study of forty-four women. Arthritis Rheum 1987;30:601–606.

    Article  PubMed  CAS  Google Scholar 

  83. Parke AL, Wilson D, Maier D. The prevalence of antiphospholipid antibodies in women with recurrent spontaneous abortion, women with successful pregnancies, and women who have never been pregnant. Arthritis Rheum 1991;34:1231–1235.

    Article  PubMed  CAS  Google Scholar 

  84. Parazzini F, Acaia B, Faden D, Lovotti M, Marelli G, Cortelazzo S. Antiphospholipid antibodies and recurrent abortion. Obstet Gynecol 1991;77:854–858.

    PubMed  CAS  Google Scholar 

  85. Out Hi, Bruinse HW, Christiaens GC, van Vliet M, Meilof JF, de Groot PG, et al. Prevalence of antiphospholipid antibodies in patients with fetal loss. Ann Rheum Dis 1991;50:553–557.

    Google Scholar 

  86. Oshiro BT, Silver RM, Scott JR, Yu H, Branch DW. Antiphospholipid antibodies and fetal death. Obstet Gynecol 1996;87:489–493.

    Article  PubMed  CAS  Google Scholar 

  87. Lockshin MD, Druzin ML, Goei S, Quamar T, Magid MS, Jovanovic L, et al. Antibody to cardiolipin predicts placental insufficiency in pregnant patients with systemic lupus erythematosus. N Engl J Med 1985;313:152–156.

    Article  PubMed  CAS  Google Scholar 

  88. Hill JA, Polgar K, Harlow BL, Anderson DJ. Evidence of embryo- and trophoblast-toxic cellular immune response(s) in women with recurrent spontaneous abortion. Am J Obstet Gynecol 1992; 166:1044–1052.

    Article  PubMed  CAS  Google Scholar 

  89. Infante-Rivard C, David M, Gauthier R, Rivard GE. Lupus anticoagulants, anticardiolipin antibodies, and fetal loss. A case-controlled study. N Engl J Med 1991;325:1063–1066.

    Article  PubMed  CAS  Google Scholar 

  90. Haddow JE, Rote NS, Dostal-Johnson D, et al. Lack of an association between late fetal death and antiphospholipid antibody measurements in the second trimester. Am J Obstet Gynecol 1991;165: 1308–1312.

    PubMed  CAS  Google Scholar 

  91. Peaceman AM, Rehnberg KA. The effect of immunoglobulin G fractions from patients with lupus anticoagulant on placental prostacyclin and thromboxane production. Am J Obstet Gynecol 1993;169: 1403–1406.

    Article  PubMed  CAS  Google Scholar 

  92. De Wolf F, Carreras LO, Moerman P, Vermylen J, Van Assche A, Renaer M. Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant. Am J Obstet Gynecol 1982;142:829–834.

    PubMed  Google Scholar 

  93. Erlendsson K, Steinsson K, Johannsson JH, Geirsson RT. Relation of antiphospholipid antibody and placental bed inflammatory vascular changes to the outcome of pregnancy in successive pregnancies of 2 women with systemic lupus erythematosus. J Rheumatol 1993;20:1779–1785.

    PubMed  CAS  Google Scholar 

  94. McNeil HP, Simpson RJ, Chesterman CN, Krilis SA. Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 1990;87:4120–4124.

    Article  PubMed  CAS  Google Scholar 

  95. Roubey RA. Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other “antiphospholipid” autoantibodies [see comments]. Blood 1994;84:2854–2867.

    PubMed  CAS  Google Scholar 

  96. Galli M, Comfurius P, Maassen C, Hemker HC, de Baets MH, van Breda-Vriesman PJ, et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor [see comments]. Lancet 1990;335:1544–1547.

    Article  PubMed  CAS  Google Scholar 

  97. Fleck RA, Rapaport SI, Rao LV. Anti-prothrombin antibodies and the lupus anticoagulant. Blood 1988;72:512–519.

    PubMed  CAS  Google Scholar 

  98. Katano K, Aoki K, Ogasawara M, Sasa H, Hayashi Y, Kawamura M, et al. Specific antiphospholipid antibodies (aPL) eluted from placentae of pregnant women with aPL-positive sera. Lupus 1995;4: 304–308.

    Article  PubMed  CAS  Google Scholar 

  99. Del Papa N, Guidali L, Sala A, Buccellati C, Khamashta MA, Ichikawa K, et al. Endothelial cells as target for antiphospholipid antibodies. Human polyclonal and monoclonal anti-beta 2-glycoprotein I antibodies react in vitro with endothelial cells through adherent beta 2-glycoprotein I and induce endothelial activation. Arthritis Rheum 1997;40:551–561.

    Article  PubMed  Google Scholar 

  100. Cowchock FS, Reece EA, Balaban D, Branch DW, Plouffe L. Repeated fetal losses associated with antiphospholipid antibodies: A collaborative randomized trial comparing prednisone with low dose heparin treatment. Am J Obstet Gynecol 1992;166:1318–1323.

    Article  PubMed  CAS  Google Scholar 

  101. Kutteh WH. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 1996;174:1584–1589.

    Article  PubMed  CAS  Google Scholar 

  102. Kutteh WH, Ermel LD. A clinical trial for the treatment of antiphospholipid antibody-associated recurrent pregnancy loss with lower dose heparin and aspirin. Am J Reprod Immunol 1996;35:402–407.

    Article  PubMed  CAS  Google Scholar 

  103. Cohen RRH, Regan MDL. Randomized controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). Br Med J 1997;314:253–257.

    Article  Google Scholar 

  104. Ermel LD, Marshburn PB, Kutteh WH. Interaction of heparin with antiphospholipid antibodies (APA) from the sera of women with recurrent pregnancy loss (RPL). Am J Reprod Immunol 1995;33:14–20. 104. Hunt BJ, Boughty HA, Majumdar G, Copplestone A, Kerslake S, Buchanan N, et al. Thromboprophylaxix with low molecular weight heparin (Fragmin) in high riskpregnancies. Thromb Haemost 1997;77: 39–43.

    Google Scholar 

  105. Druzin ML, Lockshin M, Edersheim TG, Hutson JM, Krauss AL, Kogut E. Second-trimester fetal monitoring and preterm delivery in pregnancies with systemic lupus erythematosus and/or circulating anticoagulant. Am J Obstet Gynecol 1987;157:1503–1510.

    PubMed  CAS  Google Scholar 

  106. Laskin CA, Bombardier C, Hannah ME, Mandel FP, Ritchie JW, Farewell V, et al. Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss [see comments]. N Engl J Med 1997;337:148–153.

    Article  PubMed  CAS  Google Scholar 

  107. Kaaja R, Julkunen H, Ammala P, Palosuo T, Kurki P. Intravenous immunoglobulin treatment of pregnant patients with recurrent pregnancy losses associated with antiphospholipid antibodies. Acta Obstet Gynecol Scand 1993;72:63–66.

    Article  PubMed  CAS  Google Scholar 

  108. Scott JR, Branch DW, Kochenour NK, Ward K. Intravenous immunoglobulin treatment of pregnant patients with recurrent pregnancy loss caused by antiphospholipid antibodies and Rh immunization. Am J Obstet Gynecol 1988;159:1055,1056.

    Google Scholar 

  109. Wapner RJ, Cowchock FS, Shapiro SS. Successful treatment in two women with antiphospholipid antibodies and refractory pregnancy losses with intravenous immunoglobulin infusions. Am J Obstet Gynecol 1989;161:1271,1272.

    Google Scholar 

  110. Group TGRI. Intravenous immunoglobulin in the prevention of recurrent miscarriage. Br J Obstet Gynaecol 1994;101:1072–1077.

    Article  Google Scholar 

  111. Coulam CB, Krysa L, Stern JJ, Bustillo M. Intravenous immunoglobulin for treatment of recurrent pregnancy loss. Am J Reprod Immunol 1995;34:333–337.

    Article  PubMed  CAS  Google Scholar 

  112. Christiansen OB, Mathiesen O, Husth M, Rasmussen KL, Ingerslev HJ, Lauritsen JG, et al. Placebocontrolled trial of treatment of unexplained secondary recurrent spontaneous abortions and recurrent late spontaneous abortions with i.v. immunoglobulin. Hum Reprod 1995;10:2690–2695.

    PubMed  CAS  Google Scholar 

  113. Ratko TA, Burnett DA, Foulke GE, Matuszewski KA, Sacher RA. Recommendations for off-label use of intravenously administered immunoglobulin preparations. University Hospital Consortium Expert Panel for Off-Label Use of Polyvalent Intravenously Administered Immunoglobulin Preparations [see comments]. J Am Med Assoc 1995;273:1865–1870.

    Article  CAS  Google Scholar 

  114. Schiff RI. Transmission of viral infections through intravenous immune globulin [editorial; comment] [see comments]. N Engl J Med 1994;331:1649–1650.

    Article  PubMed  CAS  Google Scholar 

  115. Harger JH, Rabin BS, Marchese SG. The prognostic value of antinuclear antibodies in women with recurrent pregnancy losses: a prospective controlled study. Obstet Gynecol 1989;73:419–424.

    PubMed  CAS  Google Scholar 

  116. Ogasawara M, Aoki K, Kajiura S, Yagami Y. Are antinuclear antibodies predictive of recurrent

    Google Scholar 

  117. miscarriage [1etter]? Lancet 1996;347:1183,1184. 117. Rosenberg AM, Bingham MC, Fong KC. Antinuclear antibodies during pregnancy. Obstet Gynecol 1986;68:560–562.

    Google Scholar 

  118. Kiuttu J, Hartikainen AL, Makitalo R, Ruuska P. The outcome of pregnancy in antinuclear antibody

    Google Scholar 

  119. positive women. Gynecol Obstet Invest 1994;37:160–163. 119. Gleicher N, el-Roeiy A, Confino E, Friberg J. Reproductive failure because of autoantibodies: unexplained infertility and pregnancy wastage. Am J Obstet Gynecol 1989;160:1376–1380; discussion 1380–1375.

    Google Scholar 

  120. Hill IA, Anderson DJ. Blood transfusions for recurrent abortion: is the treatment worse than the disease [letter]? Fertil Steril 1986;46:152–154.

    PubMed  CAS  Google Scholar 

  121. Hill IA. Immunotherapy for recurrent pregnancy loss: “Standard of care or buyer beware.” J Soc Gynecol Invest 1997;4:267–273.

    Article  CAS  Google Scholar 

  122. Gleicher N. Introduction-the worldwide collaborative observational study and MULTI-analysis on allogeneic leukocyte immunotherapy for recurrent abortion [editorial; comment]. Am J Reprod Immunol 1994;32:53,54.

    Google Scholar 

  123. Stagnaro-Green A, Roman SH, Cobin RH, el-Harazy E, Alvarez-Marfany M, Davies TF. Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies [see comments]. J Am Med Assoc 1990:264:1422–1425.

    Article  CAS  Google Scholar 

  124. Glinoer D, Soto MF, Bourdoux P, Lejeune B, Delange F, Lemone M, et al. Pregnancy in patients with mild thyroid abnormalities: maternal and neonatal repercussions. I Clin Endocrinol Metab 1991;73: 421–427.

    Article  CAS  Google Scholar 

  125. Singh A, Dantas ZN, Stone SC, Asch RH. Presence of thyroid antibodies in early reproductive failure: biochemical versus clinical pregnancies. Fertil Steril 1995;63:277–281.

    PubMed  CAS  Google Scholar 

  126. Pratt D, Novotny M, Kaberlein G, Dudkiewicz A, Gleicher N. Antithyroid antibodies and the association with non-organ-specific antibodies in recurrent pregnancy loss [see comments]. Am J Obstet Gynecol 1993;168:837–841.

    Article  PubMed  CAS  Google Scholar 

  127. Guttmacher AF. Factors affecting normal expectancy of conception. J Am Med Assoc 1956;161: 855–860.

    Article  PubMed  CAS  Google Scholar 

  128. Hull MG, Glazener CM, Kelly NJ, Conway DI, Foster PA, Hinton RA, et al. Population study of causes, treatment, and outcome of infertility. Br Med J (Clin Res Ed) 1985;291:1693–1697.

    Article  CAS  Google Scholar 

  129. Roussev RG, Stern JJ, Thorsell LP, Thomason EJ, Coulam CB. Validation of an embryotoxicity assay. Am J Reprod Immunol 1995;33:171–175.

    Article  PubMed  CAS  Google Scholar 

  130. Birdsall MA, Lockwood GM, Ledger WL, Johnson PM, Chamley LW. Antiphospholipid antibodies in women having in-vitro fertilization [see comments]. Hum Reprod 1996;11:1185–1189.

    Article  PubMed  CAS  Google Scholar 

  131. Kutteh WH, Yetman DL, Chantilis SJ, Crain J. Effect of antiphospholipid antibodies in women undergoing in-vitro fertilization: role of heparin and aspirin. Hum Reprod 1997;12:1171–1175.

    Article  PubMed  CAS  Google Scholar 

  132. Birkenfeld A, Mukaida T, Minichiello L, Jackson M, Kase NG, Yemini M. Incidence of autoimmune antibodies in failed embryo transfer cycles. Am J Reprod Immunol 1994;31:65–68.

    Article  PubMed  CAS  Google Scholar 

  133. el-Roeiy A, Gleicher N, Friberg J, Confino E, Dudkiewicz A. Correlation between peripheral blood and follicular fluid autoantibodies and impact on in vitro fertilization. Obstet Gynecol 1987;70: 163–170.

    PubMed  CAS  Google Scholar 

  134. Geva E, Amit A, Lerner-Geva L, Azem F, Yovel I, Lessing JB. Autoimmune disorders: another possible cause for in-vitro fertilization and embryo transfer failure. Hum Reprod 1995;10:2560–2563.

    PubMed  CAS  Google Scholar 

  135. Gleicher N, Liu HC, Dudkiewicz A, Rosenwaks Z, Kaberlein G, Pratt D, et al. Autoantibody profiles and immunoglobulin levels as predictors of in vitro fertilization success [see comments]. Am J Obstet Gynecol 1994;170:1145–1149.

    Article  PubMed  CAS  Google Scholar 

  136. Kowalik A, Vichnin M, Liu HC, Branch W, Berkeley AS. Midfollicular anticardiolipin and antiphosphatidylserine antibody titers do not correlate with in vitro fertilization outcome. Fertil Steril 1997;68: 298–304.

    Article  PubMed  CAS  Google Scholar 

  137. Nip MM, Taylor PV, Rutherford AJ, Hancock KW. Autoantibodies and antisperm antibodies in sera and follicular fluids of infertile patients; relation to reproductive outcome after in- vitro fertilization. Hum Reprod 1995;10:2564–2569.

    PubMed  CAS  Google Scholar 

  138. Porter TF, Hatasaka HH, Branch DW, Silver RM, Cramer DW, Hill JA. Antiphospholipid antibodies in women undergoing in vitro fertilization. Society for Gynecologic Investigation--45th Annual Meeting. Atlanta, GA, Elsevier, 1998, p. 88A.

    Google Scholar 

  139. Fisch B, Fried S, Manor Y, Ovadia J, Witz IP, Yron I. Increased antiphospholipid antibody activity in in-vitro fertilization patients is not treatment-dependent but rather an inherent characteristic of the infertile state. Am J Reprod Immunol 1995;34:370–374.

    Article  PubMed  CAS  Google Scholar 

  140. Sher G, Feinman M, Zouves C, Kuttner G, Maassarani G, Salem R, et al. High fecundity rates following in-vitro fertilization and embryo transfer in antiphospholipid antibody seropositive women treated with heparin and aspirin. Hum Reprod 1994;9:2278–2283.

    PubMed  CAS  Google Scholar 

  141. Chow WH, Daling JR, Cates W, Greenberg RS. Epidemiology of ectopic pregnancy. Epidemiol Rev 1987;9:70–94.

    PubMed  CAS  Google Scholar 

  142. Marchbanks PA, Annegers JF, Coulam CB, Strathy JH, Kurland LT. Risk factors for ectopic pregnancy. A population-based study. J Am Med Assoc 1988;259:1823–1827.

    Article  CAS  Google Scholar 

  143. Chow JM, Yonekura ML, Richwald GA, Greenland S, Sweet RL, SchachterJ. The association between Chlamydia trachomatis and ectopic pregnancy. J Am Med Assoc 1990;263:3164–3167.

    Article  CAS  Google Scholar 

  144. Brunham RC, Peeling R, Maclean I, Kosseim ML, Paraskevas M. Chlamydia trachomatis-associated ectopic pregnancy: serologic and histologic correlates. J Infect Dis 1992;165:1076–1081.

    Article  PubMed  CAS  Google Scholar 

  145. Wagar EA, Schachter J, Bavoil P, Stephens RS. Differential human serologic response to two 60,000 molecular weight Chlamydia trachomatis antigens. J Infect Dis 1990;162:922–927.

    Article  PubMed  CAS  Google Scholar 

  146. Morrison RP, Belland RJ, Lyng K, Caldwell HD. Chlamydial disease pathogenesis. The 57-kD chlamydial hypersensitivity antigen is a stress response protein. J Exp Med 1989;170:1271–1283.

    Article  PubMed  CAS  Google Scholar 

  147. Morrison RP, Lyng K, Caldwell HD. Chlamydial disease pathogenesis. Ocular hypersensitivity elicited by a genus-specific 57-kD protein. J Exp Med 1989;169:663–675.

    Article  PubMed  CAS  Google Scholar 

  148. Cerrone MC, Ma JJ, Stephens RS. Cloning and sequence of the gene for heat shock protein 60 from Chlamydia trachomatis and immunological reactivity of the protein. Infect Immun 1991;59:79–90.

    PubMed  CAS  Google Scholar 

  149. Guzick DS. Clinical epidemiology of endometriosis and infertility. Obstet Gynecol Clin North Am 1989;16:43–59.

    PubMed  CAS  Google Scholar 

  150. Koninckx PR, Meuleman C, Demeyere S, Lesaffre E, Cornillie FJ. Suggestive evidence that pelvic endometriosis is a progressive disease, whereas deeply infiltrating endometriosis is associated with pelvic pain [see comments]. Fertil Steril 1991;55:759–765.

    PubMed  CAS  Google Scholar 

  151. Prentice A, Randall BJ, Weddell A, McGill A, Henry L, Horne CH, et al. Ovarian steroid receptor expression in endometriosis and in two potential parent epithelia: endometrium and peritoneal mesothelium. Hum Reprod 1992;7:1318–1325.

    PubMed  CAS  Google Scholar 

  152. Bergqvist A, Ferno M. Oestrogen and progesterone receptors in endometriotic tissue and endometrium: comparison of different cycle phases and ages. Hum Reprod 1993;8:2211–2217.

    PubMed  CAS  Google Scholar 

  153. Bergqvist IA. Hormonal regulation of endometriosis and the rationales and effects of gonadotropinreleasing hormone agonist treatment: a review. Hum Reprod 1995;10:446–452.

    Article  PubMed  CAS  Google Scholar 

  154. Gargiulo AR, Hornstein MD. The role of GnRH agonists plus add-back therapy in the treatment of endometriosis. Semin Reprod Endocrinol 1997;15:273–284.

    Article  PubMed  CAS  Google Scholar 

  155. Sampson JA. Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the pelvic cavity. Am J Obstet Gynecol 1927;14:422–469.

    Google Scholar 

  156. Blumenkrantz MJ, Gallagher N, Bashore RA, Tenckhoff H. Retrograde menstruation in women undergoing chronic peritoneal dialysis. Obstet Gynecol 1981;57:667–670.

    PubMed  CAS  Google Scholar 

  157. Halme J, Hammond MG, Hulka JF, Raj SG, Talbert LM. Retrograde menstruation in healthy women and in patients with endometriosis. Obstet Gynecol 1984;64:151–154.

    PubMed  CAS  Google Scholar 

  158. Koninckx PR, Ide P, Vanderbroucke W, Brosens IA. New aspects of the pathophysiology of endometriosis and associated fertility. J Reprod Med 1980;24:257–260.

    PubMed  CAS  Google Scholar 

  159. Dmowski WP, Steele RW, Baker GF. Deficient cellular immunity in endometriosis. Am J Obstet Gynecol1981;141:377–383.

    Google Scholar 

  160. Hill JA. Immunology and endometriosis. Fact, artifact, or epiphenomenon? Obstet Gynecol Clin North Am 1997;24:291–306.

    Article  Google Scholar 

  161. Oosterlynck DJ, Cornillie FJ, Waer M, Vandeputte M, Koninckx PR. Women with endometriosis show a defect in natural killer activity resulting in a decreased cytotoxicity to autologous endometrium. Fertil Steril 1991;56:45–51.

    Google Scholar 

  162. Vigano P, Vercellini P, Di Blasio AM, Colombo A, Candiani GB, Vignali M. Deficient antiendometrium lymphocyte-mediated cytotoxicity in patients with endometriosis. Fertil Steril 1991;56:894–899.

    Google Scholar 

  163. Chihal HJ, Mathur S, Holtz GL, Williamson HO. An endometrial antibody assay in the clinical diagnosis and management of endometriosis. Fertil Steril 1986;46:408–411.

    PubMed  CAS  Google Scholar 

  164. Confino E, Harlow L, Gleicher N. Peritoneal fluid and serum autoantibody levels in patients with endometriosis. Fertil Steril 1990;53:242–245.

    PubMed  CAS  Google Scholar 

  165. Garza D, Mathur S, Dowd MM, Smith LF, Williamson HO. Antigenic differences between the endometrium of women with and without endometriosis. J Reprod Med 1991;36:177–182.

    PubMed  CAS  Google Scholar 

  166. Kennedy SH, Nunn B, Cederholm-Williams SA, Barlow DH. Cardiolipin antibody levels in endometriosis and systemic lupus erythematosus [see comments]. Fertil Steril 1989;52:1061–1062.

    PubMed  CAS  Google Scholar 

  167. Kilpatrick DC, Haining RE, Smith SS. Are cardiolipin antibody levels elevated in endometriosis? Fertil Steril 1991;55:436,437.

    Google Scholar 

  168. Mathur S, Garza DE, Smith LF. Endometrial autoantigens eliciting immunoglobulin (Ig)G, IgA, and IgM responses in endometriosis. Fertil Steril 1990;54:56–63.

    PubMed  CAS  Google Scholar 

  169. Switchenko AC, Kauffman RS, Becker M. Are there antiendometrial antibodies in sera of women with endometriosis [see comments]. Fertil Steril 1991;56:235–241.

    PubMed  CAS  Google Scholar 

  170. Wild RA, Shivers CA, Medders D. Detection of antiendometrial antibodies in patients with endometriosis: methodological issues. Fertil Steril 1992;58:518–521.

    PubMed  CAS  Google Scholar 

  171. Malinak LR, Buttram VC Jr, Elias S, Simpson JL. Heritage aspects of endometriosis. II. Clinical characteristics of familial endometriosis. Am J Obstet Gynecol 1980;137:332–337.

    PubMed  CAS  Google Scholar 

  172. Maxwell C, Kilpatrick DC, Haining R, Smith SK. No HLA-DR specificity is associated with endometriosis. Tissue Antigens 1989;34:145–147.

    Article  PubMed  CAS  Google Scholar 

  173. Simpson JL, Malinak LR, Elias S, Carson SA, Radvany RA. HLA associations in endometriosis. Am J Obstet Gynecol 1984;148:395–397.

    PubMed  CAS  Google Scholar 

  174. Oliker AJ, Harris AE. Endometriosis of the bladder in a male patient. J Urol 1971;106:858.

    PubMed  CAS  Google Scholar 

  175. Schrodt GR, Alcorn MO, Ibanez J. Endometriosis of the male urinary system: a case report. J Urol 1980;124:722–723.

    PubMed  CAS  Google Scholar 

  176. Gleicher N, Dmowski WP, Siegel I, Liu TL, Friberg J, Radwanska E, et al. Lymphocyte subsets in endometriosis. Obstet Gynecol 1984;63:463–466.

    PubMed  CAS  Google Scholar 

  177. Steele RW, Dmowski WP, Marmer DJ. Immunologic aspects of human endometriosis. Am J Reprod Immunol 1984;6:33–36.

    Article  PubMed  CAS  Google Scholar 

  178. Oosterlynck DJ, Lacquet FA, Waer M, Koninckx PR. Lymphokine-activated killer activity in women with endometriosis. Gynecol Obstet Invest 1994;37:185–190.

    Article  PubMed  CAS  Google Scholar 

  179. Hill JA. Immunology and endometriosis. Fertil Steril 1992;58:262–264.

    PubMed  CAS  Google Scholar 

  180. D’Hooghe TM, Scheerlinck JP, Koninckx PR, Hill JA, Bambra CS. Anti-endometrial lymphocytotoxicity and natural killer cell activity in baboons (Papio anubis and Papio cynocephalus) with endometriosis. Hum Reprod 1995;10:558–562.

    PubMed  Google Scholar 

  181. D’Hooghe TM, Hill JA. Killer cell activity, statistics, and endometriosis [letter; comment]. Fertil Steril 1995;64:226–228.

    PubMed  Google Scholar 

  182. Halme J, Becker S, Hammond MG, Raj MH, Raj S. Increased activation of pelvic macrophages in infertile women with mild endometriosis. Am J Obstet Gynecol 1983;145:333–337.

    PubMed  CAS  Google Scholar 

  183. Halme J, Becker S, Wing R. Accentuated cyclic activation of peritoneal macrophages in patients with endometriosis. Am J Obstet Gynecol 1984;148:85–90.

    PubMed  CAS  Google Scholar 

  184. Halme J, Becker S, Haskill S. Altered maturation and function of peritoneal macrophages: possible role in pathogenesis of endometriosis. Am J Obstet Gynecol 1987;156:783–789.

    PubMed  CAS  Google Scholar 

  185. Badawy SZ, Cuenca V, Marshall L, Munchback R, Rinas AC, Coble DA. Cellular components in peritoneal fluid in infertile patients with and without endometriosis. Fertil Steril 1984;42:704–708.

    PubMed  CAS  Google Scholar 

  186. Braun DP, Muriana A, Gebel H, Rotman C, Rana N, Dmowski WP. Monocyte-mediated enhancement of endometrial cell proliferation in women with endometriosis. Fertil Steril 1994;61:78–84.

    PubMed  CAS  Google Scholar 

  187. Isaacson KB, Galman M, Coutifaris C, Lyttle CR. Endometrial synthesis and secretion of complement

    Google Scholar 

  188. component-3 by patients with and without endometriosis. Fertil Steril 1990;53:836–841. 188. Khorram O, Taylor RN, Ryan IP, Schall TJ, Landers DV. Peritoneal fluid concentrations of the cytokine RANTES correlate with the severity of endometriosis. Am J Obstet Gynecol 1993;169:1545–1549.

    Article  Google Scholar 

  189. Ryan IP, Tseng JF, Schriock ED, Khorram O, Landers DV, Taylor RN. Interleukin-8 concentrations are elevated in peritoneal fluid of women with endometriosis. Fertil Steril 1995;63:929–932.

    PubMed  CAS  Google Scholar 

  190. Le J, Vilcek J. Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. Lab Invest 1987;56:234–248.

    PubMed  CAS  Google Scholar 

  191. Tabibzadeh S, Kong QF, Satyaswaroop PG, Zupi E, Marconi D, Romanini C, et al. Distinct regional and menstrual cycle dependent distribution of apoptosis in human endometrium. Potential role of

    Google Scholar 

  192. T cells and TNF-alpha. Endocr J 1994;2:87–95. 192. Tabibzadeh S, Kong QF, Sun XZ. Regulatory roles of TNF-alpha on transepithelial migration of leukocytes and epithelial dyscohesion. Endocr J 1993;1:417–425.

    Google Scholar 

  193. Philippeaux MM, Piguet PF. Expression of tumor necrosis factor-alpha and its mRNA in the endometrial mucosa during the menstrual cycle. Am J Pathol 1993;143:480–486.

    PubMed  CAS  Google Scholar 

  194. Mori H, Sawairi M, Nakagawa M, Itoh N, Wada K, Tamaya T. Peritoneal fluid interleukin-1 beta and tumor necrosis factor in patients with benign gynecologic disease. Am J Reprod Immunol 1991;26: 62–67.

    Google Scholar 

  195. Eisermann J, Gast MJ, Pineda J, Odem RR, Collins JL. Tumor necrosis factor in peritoneal fluid of women undergoing laparoscopic surgery. Fertil Steril 1988;50:573–579.

    Google Scholar 

  196. Taketani Y, Kuo TM, Mizuno M. Comparison of cytokine levels and embryo toxicity in peritoneal fluid in infertile women with untreated or treated endometriosis. Am J Obstet Gynecol 1992;167: 265–270.

    Article  PubMed  CAS  Google Scholar 

  197. Zhang RJ, Wild RA, Ojago JM. Effect of tumor necrosis factor-alpha on adhesion of human endometrial stromal cells to peritoneal mesothelial cells: an in vitro system. Fertil Steril 1993;59:1196–1201.

    PubMed  CAS  Google Scholar 

  198. Noble LS, Simpson ER, Johns A, Bulun SE. Aromatase expression in endometriosis. J Clin Endocrinol Metab 1996;81:174–179.

    Article  PubMed  CAS  Google Scholar 

  199. Ininns EK, Gatanaga M, Cappuccini F, Dett CA, Yamamoto RS, Granger GA, et al. Growth of the endometrial adenocarcinoma cell line AN3 CA is modulated by tumor necrosis factor and its receptor is up-regulated by estrogen in vitro. Endocrinology 1992;130:1852–1856.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Antonio R. Gargiulo MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joseph A. Hill MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Endocrinology, Department of Medicine, The Wellesley Hospital, University of Toronto, Toronto, Ontario, Canada

    Robert Volpé MD, FRCP(C), FACP, FRCP

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Science+Business Media New York

About this chapter

Cite this chapter

Gargiulo, A.R., Hill, J.A. (1999). Autoimmune Endocrinopathies in Female Reproductive Dysfunction. In: Volpé, R. (eds) Autoimmune Endocrinopathies. Contemporary Endocrinology, vol 15. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-704-8_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-704-8_16

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4757-4572-6

  • Online ISBN: 978-1-59259-704-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation